COMMUNIQUÉS West-GlobeNewswire

Research Team Wins Heinz Maurer Award for Linking Bacterium to Eczema Barrier Failure
01/09/2026
Using Lipotype's lipidomics platform, scientists map how Staphylococcus hominis affects the skin's lipid environment in atopic dermatitis, opening promising pathways for eczema treatment DRESDEN, Germany, Sept. 01, 2026 [...]
Haypp Group to Participate in Key Global Tobacco and Nicotine Conferences This Fall
01/09/2026
Washington, D.C, USA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Haypp Group , parent company of U.S. online nicotine pouch retailers Nicokick.com and Northerner.com , today announced that its leadership will participate in [...]
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
01/09/2026
BRIDGEWATER N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executive Officer, will [...]
Voyager to Present at Upcoming Investor Conferences
01/09/2026
LEXINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company [...]
Nurix Therapeutics to Participate in Upcoming September Investor Conferences
01/09/2026
BRISBANE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
01/09/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 01, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“ CDT ” or the “ Company ”) today announced the appointment of James Bligh, co-founder of Conduit [...]
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
01/09/2026
Oak Ridge, TN, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to [...]
Kinjirushi Introduces Hexaraphane and Research Into Its Potential Brain Health Benefits to North America
01/09/2026
Japanese wasabi specialist brings decades of expertise to North America as research explores the relationship between wasabi-derived compounds, cognitive function and healthy aging TORRANCE, Calif., Sept. 01, 2026 ( [...]
Sofwave to Participate in the Wells Fargo 21st Annual Healthcare Conference
01/09/2026
SAN CLEMENTE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today [...]
ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
01/09/2026
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in [...]
Belite Bio to Participate in Four Upcoming Investor Conferences
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio ® ” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
01/09/2026
FLORHAM PARK, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) [...]
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
01/09/2026
CORAL GABLES, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and [...]
Septerna to Participate in Upcoming Investor Conferences
01/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
01/09/2026
New cross-species capability is designed to help pharma distinguish rat-specific liver toxicity from risks that may translate to humans SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) ( [...]
Biomerica Reports Fiscal 2026 Year-End Financial Results
01/09/2026
Fiscal 2026 fourth quarter net sales increased approximately 17% compared to the fourth quarter of fiscal 2025 Full-year net loss improved by approximately 24% to approximately $3.8 million InFoods IBS update: 100% of [...]
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
01/09/2026
Abstracts highlight potential of Autonomix’s transvascular technology across pain management and nervous system mapping THE WOODLANDS, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“ [...]
Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference
01/09/2026
Company to Highlight Growth Strategy and Readiness for 2026 Commercial Launch of FDA-Cleared DeepView® System for Burn Indication DALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI [...]
Conexeu Sciences Sets September and October 2026 Conference Schedule
01/09/2026
RENO, Nev., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage biotechnology company advancing an investigational tissue-restoration platform, is [...]

Pages